Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimox2 Study in Metastatic Colorectal Cancer
NCT00274872Phase 3Unknown
- Sponsor
- GERCOR
- Start
- Jan 2004
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, folinic acid, fluorouracil in colorectal cancer (CRC), sponsored by GERCOR. Status: unknown.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00274872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274872.